Equillium Inc (EQ)
0.6842
-0.10
(-12.33%)
USD |
NASDAQ |
Nov 14, 16:00
0.6704
-0.01
(-2.02%)
After-Hours: 05:43
Equillium Cash from Financing (Quarterly): 0.091M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.091M |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.079M |
September 30, 2023 | -0.26M |
June 30, 2023 | -7.618M |
March 31, 2023 | -1.429M |
December 31, 2022 | -1.356M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.141M |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.225M |
September 30, 2021 | 0.174M |
June 30, 2021 | 0.698M |
Date | Value |
---|---|
March 31, 2021 | 29.96M |
December 31, 2020 | 0.011M |
September 30, 2020 | 53.06M |
June 30, 2020 | 0.096M |
March 31, 2020 | 0.775M |
December 31, 2019 | -0.105M |
September 30, 2019 | 9.941M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 64.76M |
September 30, 2018 | 0.001M |
June 30, 2018 | 1.602M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.618M
Minimum
Jun 2023
53.06M
Maximum
Sep 2020
3.924M
Average
0.079M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
Matinas BioPharma Holdings Inc | 9.189M |
Tenon Medical Inc | 0.00 |
Alphatec Holdings Inc | 6.694M |
Madrigal Pharmaceuticals Inc | 7.462M |
Spero Therapeutics Inc | -- |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 0.73M |
Cash from Investing (Quarterly) | -1.351M |
Free Cash Flow | -15.77M |
Free Cash Flow Per Share (Quarterly) | 0.0183 |
Free Cash Flow to Equity (Quarterly) | 0.668M |
Free Cash Flow to Firm (Quarterly) | 0.668M |
Free Cash Flow Yield | -65.00% |